Remarkable response to PD-1 inhibitor in a patient with extensive-stage small cell lung cancer: a case report and literature review

We report a case of a 59-year-old male diagnosed with extensive-stage small cell lung cancer (SCLC). He received first-line platinum doublet chemotherapy and second-line topotecan-based regimen, but experienced disease progression after each line of therapy. He was then treated with Sintilimab, a PD...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Ge, Liu, Xiangliang, Zhang, Xinwei, Song, Wei, Lu, Jin, Ding, Zhongyang, Chen, Xiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537924/
https://www.ncbi.nlm.nih.gov/pubmed/37781394
http://dx.doi.org/10.3389/fimmu.2023.1267606

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537924/
https://www.ncbi.nlm.nih.gov/pubmed/37781394
http://dx.doi.org/10.3389/fimmu.2023.1267606

Ejemplares similares